SMARCA4 and rheumatoid arthritis: Finally, we postulate the clinical role of survivin-BRG1/SWI complex axis in pathogenic CD4+ cells abundant in synovia of patients with rheumatoid arthritis, and the ability of anti-rheumatic drugs to modulate the DNA damage response.